Journal of Diabetes (Jun 2024)
Diabetes and gastric cancer incidence and mortality in the Asia Cohort Consortium: A pooled analysis of more than a half million participants
- Katherine De la Torre,
- Minkyo Song,
- Sarah Krull Abe,
- Md. Shafiur Rahman,
- Md. Rashedul Islam,
- Eiko Saito,
- Sukhong Min,
- Dan Huang,
- Yu Chen,
- Prakash C. Gupta,
- Norie Sawada,
- Akiko Tamakoshi,
- Xiao‐Ou Shu,
- Wanqing Wen,
- Ritsu Sakata,
- Jeongseon Kim,
- Chisato Nagata,
- Hidemi Ito,
- Sue K. Park,
- Myung‐Hee Shin,
- Mangesh S. Pednekar,
- Shoichiro Tsugane,
- Takashi Kimura,
- Yu‐Tang Gao,
- Hui Cai,
- Keiko Wada,
- Isao Oze,
- Aesun Shin,
- Yoon‐Ok Ahn,
- Habibul Ahsan,
- Paolo Boffetta,
- Kee Seng Chia,
- Keitaro Matsuo,
- You‐Lin Qiao,
- Nathaniel Rothman,
- Wei Zheng,
- Manami Inoue,
- Daehee Kang
Affiliations
- Katherine De la Torre
- Department of Biomedical Sciences Seoul National University Graduate School Seoul Korea
- Minkyo Song
- Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland USA
- Sarah Krull Abe
- Division of Prevention National Cancer Center Institute for Cancer Control Tokyo Japan
- Md. Shafiur Rahman
- Division of Prevention National Cancer Center Institute for Cancer Control Tokyo Japan
- Md. Rashedul Islam
- Division of Prevention National Cancer Center Institute for Cancer Control Tokyo Japan
- Eiko Saito
- Institute for Global Health Policy Research, National Center for Global Health and Medicine Tokyo Japan
- Sukhong Min
- Department of Preventive Medicine Seoul National University College of Medicine Seoul Korea
- Dan Huang
- Department of Preventive Medicine Seoul National University College of Medicine Seoul Korea
- Yu Chen
- Department of Population Health and Environmental Medicine NYU Grossman School of Medicine New York New York USA
- Prakash C. Gupta
- Healis – Sekhsaria Institute for Public Health Navi Mumbai India
- Norie Sawada
- Division of Cohort Research National Cancer Center Institute for Cancer Control Tokyo Japan
- Akiko Tamakoshi
- Department of Public Health Hokkaido University Faculty of Medicine Sapporo Japan
- Xiao‐Ou Shu
- Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center Vanderbilt‐Ingram Cancer Center Vanderbilt University Medical Center Nashville Tennessee USA
- Wanqing Wen
- Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center Vanderbilt‐Ingram Cancer Center Vanderbilt University Medical Center Nashville Tennessee USA
- Ritsu Sakata
- Radiation Effects Research Foundation Hiroshima Japan
- Jeongseon Kim
- Graduate School of Cancer Science and Policy, National Cancer Center Goyang Korea
- Chisato Nagata
- Department of Epidemiology and Preventive Medicine Gifu University Graduate School of Medicine Gifu Japan
- Hidemi Ito
- Department of Preventive Medicine, Division of Cancer Information and Control Aichi Cancer Center Research Institute Nagoya Japan
- Sue K. Park
- Department of Preventive Medicine Seoul National University College of Medicine Seoul Korea
- Myung‐Hee Shin
- Department of Social and Preventive Medicine Sungkyunkwan University School of Medicine Seoul Korea
- Mangesh S. Pednekar
- Healis – Sekhsaria Institute for Public Health Navi Mumbai India
- Shoichiro Tsugane
- Division of Cohort Research National Cancer Center Institute for Cancer Control Tokyo Japan
- Takashi Kimura
- Department of Public Health Hokkaido University Faculty of Medicine Sapporo Japan
- Yu‐Tang Gao
- Department of Epidemiology Shanghai Cancer Institute Shanghai China
- Hui Cai
- Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center Vanderbilt‐Ingram Cancer Center Vanderbilt University Medical Center Nashville Tennessee USA
- Keiko Wada
- Department of Epidemiology and Preventive Medicine Gifu University Graduate School of Medicine Gifu Japan
- Isao Oze
- Division of Cancer Epidemiology and Prevention Aichi Cancer Center Research Institute Nagoya Japan
- Aesun Shin
- Department of Preventive Medicine Seoul National University College of Medicine Seoul Korea
- Yoon‐Ok Ahn
- Department of Preventive Medicine Seoul National University College of Medicine Seoul Korea
- Habibul Ahsan
- Department of Public Health Sciences University of Chicago Chicago Illinois USA
- Paolo Boffetta
- Stony Brook Cancer Center, Stony Brook University Stony Brook New York USA
- Kee Seng Chia
- Saw Swee Hock School of Public Health, National University of Singapore Singapore Singapore
- Keitaro Matsuo
- Division of Cancer Epidemiology and Prevention Aichi Cancer Center Research Institute Nagoya Japan
- You‐Lin Qiao
- School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China
- Nathaniel Rothman
- Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland USA
- Wei Zheng
- Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center Vanderbilt‐Ingram Cancer Center Vanderbilt University Medical Center Nashville Tennessee USA
- Manami Inoue
- Division of Prevention National Cancer Center Institute for Cancer Control Tokyo Japan
- Daehee Kang
- Department of Preventive Medicine Seoul National University College of Medicine Seoul Korea
- DOI
- https://doi.org/10.1111/1753-0407.13561
- Journal volume & issue
-
Vol. 16,
no. 6
pp. n/a – n/a
Abstract
Abstract Background Evidence suggests a possible link between diabetes and gastric cancer risk, but the findings remain inconclusive, with limited studies in the Asian population. We aimed to assess the impact of diabetes and diabetes duration on the development of gastric cancer overall, by anatomical and histological subtypes. Methods A pooled analysis was conducted using 12 prospective studies included in the Asia Cohort Consortium. Among 558 981 participants (median age 52), after a median follow‐up of 14.9 years and 10.5 years, 8556 incident primary gastric cancers and 8058 gastric cancer deaths occurred, respectively. Cox proportional hazard regression models were used to estimate study‐specific hazard ratios (HRs) and 95% confidence intervals (CIs) and pooled using random‐effects meta‐analyses. Results Diabetes was associated with an increased incidence of overall gastric cancer (HR 1.15, 95% CI 1.06–1.25). The risk association did not differ significantly by sex (women vs men: HR 1.31, 95% CI 1.07–1.60 vs 1.12, 1.01–1.23), anatomical subsites (noncardia vs cardia: 1.14, 1.02–1.28 vs 1.17, 0.77–1.78) and histological subtypes (intestinal vs diffuse: 1.22, 1.02–1.46 vs 1.00, 0.62–1.61). Gastric cancer risk increased significantly during the first decade following diabetes diagnosis (HR 4.70, 95% CI 3.77–5.86), and decreased with time (nonlinear p < .01). Positive associations between diabetes and gastric cancer mortality were observed (HR 1.15, 95% CI 1.03–1.28) but attenuated after a 2‐year time lag. Conclusion Diabetes was associated with an increased gastric cancer incidence regardless of sex, anatomical subsite, or subtypes of gastric cancer. The risk of gastric cancer was particularly high during the first decade following diabetes diagnosis.
Keywords